94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES

Detalles Bibliográficos
Autores principales: Chauhan, Mahak, Nzeako, Ihechiluru E., Li, Feng, Thuluvath, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212385/
http://dx.doi.org/10.1016/S0016-5085(22)60037-4
_version_ 1784730573558775808
author Chauhan, Mahak
Nzeako, Ihechiluru E.
Li, Feng
Thuluvath, Paul J.
author_facet Chauhan, Mahak
Nzeako, Ihechiluru E.
Li, Feng
Thuluvath, Paul J.
author_sort Chauhan, Mahak
collection PubMed
description
format Online
Article
Text
id pubmed-9212385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92123852022-06-22 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES Chauhan, Mahak Nzeako, Ihechiluru E. Li, Feng Thuluvath, Paul J. Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212385/ http://dx.doi.org/10.1016/S0016-5085(22)60037-4 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Chauhan, Mahak
Nzeako, Ihechiluru E.
Li, Feng
Thuluvath, Paul J.
94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title_full 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title_fullStr 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title_full_unstemmed 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title_short 94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
title_sort 94: antibody response after a booster dose of sars-cov-2 vaccine in liver transplant recipients and those with chronic liver diseases
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212385/
http://dx.doi.org/10.1016/S0016-5085(22)60037-4
work_keys_str_mv AT chauhanmahak 94antibodyresponseafteraboosterdoseofsarscov2vaccineinlivertransplantrecipientsandthosewithchronicliverdiseases
AT nzeakoihechilurue 94antibodyresponseafteraboosterdoseofsarscov2vaccineinlivertransplantrecipientsandthosewithchronicliverdiseases
AT lifeng 94antibodyresponseafteraboosterdoseofsarscov2vaccineinlivertransplantrecipientsandthosewithchronicliverdiseases
AT thuluvathpaulj 94antibodyresponseafteraboosterdoseofsarscov2vaccineinlivertransplantrecipientsandthosewithchronicliverdiseases

Ejemplares similares